| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
34,330,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Vaccitech is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. Co.'s therapeutic programs include VTP-300 for the treatment of chronic hepatitis B infection, or CHB, VTP-200 for the treatment of human papilloma virus infection, or HPV, VTP-850 for the treatment of prostate cancer and VTP-600 for the treatment of non-small cell lung cancer, or NSCLC. Co.'s prophylactic programs include VTP-400 for the prevention of herpes zoster, or shingles, and VTP-500 for the prevention of Middle East respiratory syndrome, or MERS.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
23,750 |
23,750 |
| Total Buy Value |
$0 |
$0 |
$61,012 |
$61,012 |
| Total People Bought |
0 |
0 |
2 |
2 |
| Total Buy Transactions |
0 |
0 |
2 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
84,133 |
| Total Sell Value |
$0 |
$0 |
$0 |
$461,553 |
| Total People Sold |
0 |
0 |
0 |
3 |
| Total Sell Transactions |
0 |
0 |
0 |
14 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Enright William |
Chief Executive Officer |
• • – |
2023-03-27 |
4 |
S |
$2.42 |
$36,299 |
I/I |
(15,000) |
728,454 |
|
- |
|
| M&g Investment Management Ltd |
10% Owner |
– – • |
2022-09-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,108,752 |
5,197,349 |
|
- |
|
| M&g Alternatives Investment Management Ltd |
10% Owner |
– – • |
2022-09-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,108,752) |
0 |
|
- |
|
| Ellis Christopher |
Chief Operating Officer |
• – – |
2022-08-25 |
4 |
S |
$5.69 |
$257,396 |
D/D |
(39,176) |
75 |
|
- |
|
| Ellis Christopher |
Chief Operating Officer |
• – – |
2022-08-25 |
4 |
OE |
$0.00 |
$16 |
D/D |
39,176 |
39,251 |
|
- |
|
| Griffiths Graham |
Chief Business Officer |
• – – |
2022-08-25 |
4 |
S |
$7.39 |
$73,870 |
D/D |
(10,000) |
104,209 |
|
- |
|
| Ellis Christopher |
Chief Operating Officer |
• – – |
2022-08-24 |
4 |
S |
$4.78 |
$2,152 |
D/D |
(450) |
75 |
|
- |
|
| Ellis Christopher |
Chief Operating Officer |
• – – |
2022-08-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
450 |
525 |
|
- |
|
| Ellis Christopher |
Chief Operating Officer |
• – – |
2022-08-18 |
4 |
S |
$4.84 |
$10,531 |
D/D |
(2,175) |
75 |
|
- |
|
| Ellis Christopher |
Chief Operating Officer |
• – – |
2022-08-18 |
4 |
OE |
$0.00 |
$1 |
D/D |
2,175 |
2,250 |
|
- |
|
| Ellis Christopher |
Chief Operating Officer |
• – – |
2022-08-17 |
4 |
S |
$4.77 |
$3,093 |
D/D |
(649) |
75 |
|
- |
|
| Ellis Christopher |
Chief Operating Officer |
• – – |
2022-08-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
649 |
724 |
|
- |
|
| Griffiths Graham |
Chief Business Officer |
• – – |
2022-08-17 |
4 |
S |
$4.76 |
$2,381 |
D/D |
(500) |
114,209 |
|
- |
|
| Griffiths Graham |
Chief Business Officer |
• – – |
2022-08-16 |
4 |
S |
$4.82 |
$5,876 |
D/D |
(1,220) |
114,709 |
|
- |
|
| Ellis Christopher |
Chief Operating Officer |
• – – |
2022-08-16 |
4 |
S |
$4.78 |
$10,513 |
D/D |
(2,200) |
75 |
|
- |
|
| Ellis Christopher |
Chief Operating Officer |
• – – |
2022-08-16 |
4 |
OE |
$0.00 |
$1 |
D/D |
2,200 |
2,275 |
|
- |
|
| Griffiths Graham |
Chief Business Officer |
• – – |
2022-08-15 |
4 |
S |
$4.75 |
$11,407 |
D/D |
(2,400) |
115,929 |
|
- |
|
| Ellis Christopher |
Chief Operating Officer |
• – – |
2022-08-15 |
4 |
S |
$4.76 |
$25,463 |
D/D |
(5,350) |
75 |
|
- |
|
| Ellis Christopher |
Chief Operating Officer |
• – – |
2022-08-15 |
4 |
OE |
$0.00 |
$2 |
D/D |
5,350 |
5,425 |
|
- |
|
| Griffiths Graham |
Chief Business Officer |
• – – |
2022-08-12 |
4 |
S |
$4.50 |
$22,500 |
D/D |
(5,000) |
118,329 |
|
- |
|
| Ellis Christopher |
Chief Operating Officer |
• – – |
2022-06-28 |
4 |
S |
$6.00 |
$30 |
D/D |
(5) |
75 |
|
- |
|
| Ellis Christopher |
Chief Operating Officer |
• – – |
2022-06-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5 |
80 |
|
- |
|
| Griffiths Graham |
Chief Business Officer |
• – – |
2022-06-24 |
4 |
A |
$5.87 |
$587 |
D/D |
100 |
123,329 |
|
- |
|
| Griffiths Graham |
Chief Business Officer |
• – – |
2022-06-23 |
4 |
S |
$5.28 |
$42 |
D/D |
(8) |
123,229 |
|
- |
|
| Griffiths Graham |
Chief Business Officer |
• – – |
2022-06-23 |
4 |
OE |
$0.00 |
$3 |
D/D |
7,338 |
123,237 |
|
- |
|
45 Records found
|
|
Page 1 of 2 |
|
|
